Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. China Medical System Holdings Limited
  6. Summary
    867   KYG211081248

CHINA MEDICAL SYSTEM HOLDINGS LIMITED

(867)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Hong Kong Stock Exchange
10/18/2021 10/19/2021 10/20/2021 10/21/2021 10/22/2021 Date
14.74 14.56 15.04 14.5 14.36 Last
5075190 2308853 5310661 3537425 3070776 Volume
+1.94% -1.22% +3.30% -3.59% -0.97% Change
Estimated financial data (e)
Sales 2021 8 203 M 1 284 M 1 284 M
Net income 2021 3 226 M 505 M 505 M
Net cash position 2021 2 700 M 423 M 423 M
P/E ratio 2021 9,69x
Yield 2021 3,91%
Sales 2022 9 497 M 1 487 M 1 487 M
Net income 2022 3 618 M 566 M 566 M
Net cash position 2022 3 979 M 623 M 623 M
P/E ratio 2022 8,68x
Yield 2022 4,36%
Capitalization 29 063 M 4 552 M 4 550 M
EV / Sales 2021 3,21x
EV / Sales 2022 2,64x
Nbr of Employees 4 884
Free-Float 50,7%
More Financials
Company
China Medical System Holdings Limited is a Hong Kong-based investment holding company principally engaged in the manufacture, marketing, promotion and sales of pharmaceutical products. Its main products under direct network include Deanxit, Ursofalk, XinHuoSu, Salofalk, Bioflor and Augentropfen Stulln Mono Eye-drops, among others. Its products under the agency promotion network include ShaDuoLiKa, YiNuoShu and... 
Sector
Pharmaceuticals
Calendar
03/21Earnings Release
More about the company
Ratings of China Medical System Holdings Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about CHINA MEDICAL SYSTEM HOLDINGS LIMITED
10/15CHINA MEDICAL SYSTEM : New Drug Application for Psoriasis Treatment Accepted by Regulators
MT
10/06China Medical System Holdings Limited Announces Change of Independent Non-Executive Dir..
CI
09/27China Medical System Holdings Limited Establishes A New Programme with XF-73 Targeting ..
CI
09/22China Medical System Holdings Limited Joins BaseLaunch as Latest Partner
CI
09/14DTrade Labs Inc. announced that it has received $22.8 million in funding from Alameda R..
CI
09/07China Medical System Holdings Limited Resolves to Pay an Interim Dividend for the Six M..
CI
09/06CHINA MEDICAL SYSTEM HOLDINGS LIMITE : Ex-dividend day for interim dividend
FA
08/27China Medical System Holdings Limited commences an Equity Buyback Plan for 247,076,051 ..
CI
08/24CHINA MEDICAL SYSTEM : Posts Rise in H1 Profit, Revenue
MT
08/23China Medical System Holdings Limited Announces Interim Dividend for the Six Months End..
CI
08/23China Medical System Holdings Limited Reports Earnings Results for the Half Year Ended ..
CI
08/16CHINA MEDICAL SYSTEM : Wins Approval to Carry Out Clinical Trials of Arthritis Drug
MT
08/13National Medical Products Grants Approval to China Medical System Holdings Limited's Me..
CI
08/02CHINA MEDICAL SYSTEM : Wins Nod to Carry Out Clinical Trials of Diagnostic Drug
MT
08/02China Medical System Holdings Limited Receives Approval for Innovative Patented Drug Me..
CI
More news
News in other languages on CHINA MEDICAL SYSTEM HOLDINGS LIMITED
10/15La demande de nouveau médicament de China Medical System pour le traitement du psoriasi..
09/07China Medical System Holdings Limited décide de verser un dividende intérimaire pour le..
07/06Hong Kong-Lam invite à surveiller et dénoncer le comportement des adolescents
06/21Hong Kong-Lam défend les mesures prises contre le journal Apple Daily
05/04DGAP-NEWS : VAXIMM gibt Teilnahme an Wissenschafts- und Investorenkonferenzen im Mai bekan..
More news
Chart CHINA MEDICAL SYSTEM HOLDINGS LIMITED
Duration : Period :
China Medical System Holdings Limited Technical Analysis Chart | 867 | KYG211081248 | MarketScreener
Technical analysis trends CHINA MEDICAL SYSTEM HOLDINGS LIMITED
Short TermMid-TermLong Term
TrendsNeutralBearishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Last Close Price 11,79 CNY
Average target price 17,13 CNY
Spread / Average Target 45,2%
EPS Revisions
Managers and Directors
Kong Lam Chairman, President & Chief Executive Officer
Yan Ling Chen Chief Financial Officer, Executive Director & VP
Wai Ming Wong Chief Technical Officer
Hong Bing Chen Chief Operating Officer, Executive Director & VP
Chong Shun Leung Independent Non-Executive Director